Physician profile
James Huddleston
NPI 1457343196
$6,891.53
in general payments reported to CMS, 2019-2025
9 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $147 · 2021: $55.70 · 2022: $1,766 · 2023: $1,599 · 2024: $2,990 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,509 · Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,508.73 |
| Food and Beverage | $2,237.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,581.77 | 2022-2025 | Avenir, Rosa, Anterior Supine Stem Extractor |
| Arthrex, INC. | $1,481.88 | 2022-2023 | |
| Rock Medical Orthopedics, INC. | $1,267.75 | 2021-2024 | |
| Smith+Nephew, INC. | $629.54 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Aetos Shoulder System, Spatial Frame |
| Medtronic, INC. | $601.46 | 2023-2024 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $175.38 | 2019-2020 | |
| Catalyst Orthoscience | $127.79 | 2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System |
| Paragon 28, INC. | $13.61 | 2021 | |
| Glaxosmithkline, LLC. | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Huddleston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.